# MorphoSys AG (MOR)

Source: https://www.quantisnow.com/company/MOR
Generated: 2026-11-10T12:00:26.179Z

- Ticker: MOR
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2018
- Website: morphosys.com

## About

MorphoSys AG, together with its subsidiaries, discovers, develops and commercializes therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. Its lead product candidate is Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B cell lymphoma and chronic lymphocytic leukemia. The company develops Tremfya, an antibody to treat plaque psoriasis, psoriatic arthritis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, and adenomatous polyposis diseases; Gantenerumab, an antibody for the treatment of Alzheimer's diseases through its pharmaceutical partners; Otilimab, an antibody for rheumatoid arthritis; and MOR106, an antibody for atopic dermatitis. It also develops Felzartamab, an antibody directed against CD38, which is in Phase I/II clinical trials for the treatment of anti-PLA2R-positive membranous nephropathy, an autoimmune disease. MorphoSys AG has a regional licensing agreement with I-Mab Biopharma to develop and commercialize felzartamab in China, Taiwan, Hong Kong, and Macau; a strategic alliance with the LEO Pharma; a joint collaboration and license agreement with Incyte Corporation for the development and commercialization of MorphoSys investigational compound tafasitamab (MOR208); and a clinical collaboration with Incyte Corporation and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was founded in 1992 and is headquartered in Planegg, Germany.

## Latest MOR news and filings

- 2024-08-27 14:15 UTC [Merger Squeeze-Out of MorphoSys Minority Shareholders Approved at 2024 Annual General Meeting](https://www.quantisnow.com/insight/merger-squeeze-out-of-morphosys-minority-shareholders-approved-at-2024-annual-5672970)
- 2024-08-15 20:30 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-morphosys-ag-5661555)
- 2024-08-13 20:31 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-morphosys-ag-5657216)
- 2024-08-07 20:51 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-morphosys-ag-5648166)
- 2024-08-07 20:30 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-morphosys-ag-5648036)
- 2024-08-05 12:14 UTC [SEC Form 6-K] [SEC Form 6-K filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-morphosys-ag-5641512)
- 2024-08-02 20:30 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-morphosys-ag-5640550)
- 2024-08-01 20:30 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-morphosys-ag-5638639)
- 2024-07-31 20:30 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-morphosys-ag-5635846)
- 2024-07-30 20:30 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-morphosys-ag-5633516)
- 2024-07-29 20:30 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-morphosys-ag-5631548)
- 2024-07-25 20:30 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-morphosys-ag-5628699)
- 2024-07-25 20:05 UTC [SEC Form 25 filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-25-filed-by-morphosys-ag-5628351)
- 2024-07-18 20:30 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-morphosys-ag-5616134)
- 2024-07-18 15:25 UTC [SEC Form 6-K] [SEC Form 6-K filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-morphosys-ag-5615275)
- 2024-07-12 22:11 UTC [Market Chatter] [MorphoSys Announces Voluntary Delisting From The Nasdaq Global Market, Expects That The Last Trading Day Will Be On Or About August 2, 2024](https://www.quantisnow.com/insight/morphosys-announces-voluntary-delisting-from-the-nasdaq-global-market-expects-5606862)
- 2024-07-12 20:59 UTC [MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market](https://www.quantisnow.com/insight/morphosys-announces-voluntary-delisting-from-the-nasdaq-global-market-5606693)
- 2024-07-12 20:20 UTC [SEC Form 6-K] [SEC Form 6-K filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-morphosys-ag-5606492)
- 2024-07-11 20:30 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-morphosys-ag-5604687)
- 2024-07-05 10:48 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9 filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-sc-14d9-filed-by-morphosys-ag-5594806)
- 2024-07-05 10:02 UTC [SEC Schedule TOT] [SEC Form SC TO-T filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-sc-to-t-filed-by-morphosys-ag-5594750)
- 2024-07-02 14:18 UTC [SEC Form 6-K] [SEC Form 6-K filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-morphosys-ag-5588795)
- 2024-06-21 20:30 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-morphosys-ag-5571355)
- 2024-06-21 14:07 UTC [SEC Form 6-K] [SEC Form 6-K filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-morphosys-ag-5570323)
- 2024-06-20 20:41 UTC [SEC Form 6-K] [SEC Form 6-K filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-morphosys-ag-5569054)
- 2024-06-20 20:37 UTC [SEC Form 6-K] [SEC Form 6-K filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-morphosys-ag-5569030)
- 2024-06-20 20:33 UTC [SEC Form SC14D9C filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-sc14d9c-filed-by-morphosys-ag-5568993)
- 2024-06-20 19:38 UTC [SEC Form SC TO-C filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-sc-to-c-filed-by-morphosys-ag-5568427)
- 2024-06-20 07:13 UTC [Market Chatter] [Novartis to Squeeze Out MorphoSys Minority Shareholders, Initiate Delisting](https://www.quantisnow.com/insight/novartis-to-squeeze-out-morphosys-minority-shareholders-initiate-delisting-5566672)
- 2024-06-20 06:47 UTC [MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys' Minority Shareholders](https://www.quantisnow.com/insight/morphosys-and-novartis-sign-delisting-agreement-and-intend-to-implement-5566663)
- 2024-06-20 06:20 UTC [Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG's Minority Shareholders](https://www.quantisnow.com/insight/ad-hoc-novartis-bidco-germany-ag-intends-to-implement-a-5566659)
- 2024-06-17 20:30 UTC [SEC Schedule 13D] [Amendment: SEC Form SC 13D/A filed by MorphoSys AG](https://www.quantisnow.com/insight/amendment-sec-form-sc-13da-filed-by-morphosys-ag-5562338)
- 2024-06-10 20:30 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by MorphoSys AG (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-morphosys-ag-amendment-5548749)
- 2024-06-10 16:06 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by MorphoSys AG (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-morphosys-ag-amendment-5547841)
- 2024-06-10 15:01 UTC [SEC Form 6-K] [SEC Form 6-K filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-morphosys-ag-5547720)
- 2024-06-06 20:36 UTC [SEC Form 6-K] [SEC Form 6-K filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-morphosys-ag-5542913)
- 2024-06-05 14:22 UTC [SEC Form 6-K] [SEC Form 6-K filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-morphosys-ag-5538689)
- 2024-06-04 20:30 UTC [SEC Schedule TOT] [SEC Form SC TO-T/A filed by MorphoSys AG (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-to-ta-filed-by-morphosys-ag-amendment-5536446)
- 2024-06-04 20:06 UTC [SEC Schedule 14D-9] [SEC Form SC 14D9/A filed by MorphoSys AG (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-14d9a-filed-by-morphosys-ag-amendment-5535949)
- 2024-06-04 14:17 UTC [SEC Form 6-K] [SEC Form 6-K filed by MorphoSys AG](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-morphosys-ag-5535008)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/MOR
- Earnings history: https://www.quantisnow.com/earnings/MOR
- Dividend history: https://www.quantisnow.com/dividends/MOR
- Insider transactions: https://www.quantisnow.com/insiders/MOR
- Options chain: https://www.quantisnow.com/options/MOR
- SEC 8-K filings only: https://www.quantisnow.com/company/MOR/8-k
- RSS and alerts for MOR: https://www.quantisnow.com/docs/rss-feeds.md